Cargando…

Risk of cardiovascular disease with lipoprotein(a) in familial hypercholesterolemia: a review

INTRODUCTION: Lipoprotein(a) (Lp[a]) is a risk factor of cardiovascular disease (CVD). Familial hypercholesterolemia (FH), which exhibits high low-density lipoprotein cholesterol (LDL-C) levels, is a risk factor of CVD. The relationship of Lp(a) with CVD has been characterized in populations specifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Jun, Hamasaki, Masato, Kotani, Kazuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2020
Materias:	State of the Art Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433790/ https://www.ncbi.nlm.nih.gov/pubmed/32832714 http://dx.doi.org/10.5114/amsad.2020.97105

Ejemplares similares

Lipoprotein(a) and Familial Hypercholesterolemia: A Short Review Including the Laboratory Viewpoint
por: Hamasaki, Masato, et al.
Publicado: (2020)

Pulse wave velocity, carotid intima media thickness and flow-mediated dilation in Takayasu arteritis: a systematic review
por: Watanabe, Jun, et al.
Publicado: (2021)

Familial hypercholesterolemia in Southeast and East Asia
por: Jackson, Candace L., et al.
Publicado: (2021)

Sarcopenia and Cardiovascular Diseases
por: Damluji, Abdulla A., et al.
Publicado: (2023)

Obstructive sleep apnoea and cardiovascular disease: a literature review
por: Assallum, Hussein, et al.
Publicado: (2019)

Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients
por: Rysz-Górzyńska, Magdalena, et al.
Publicado: (2016)

Low-density lipoprotein, its susceptibility to oxidation and the role of lipoprotein-associated phospholipase A(2) and carboxyl ester lipase lipases in atherosclerotic plaque formation
por: Burchardt, Paweł, et al.
Publicado: (2013)

Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options
por: Jankowski, Joachim, et al.
Publicado: (2021)

Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus
por: Dimopoulos, Konstantinos, et al.
Publicado: (2023)

COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases
por: Zhang, Yuanyuan, et al.
Publicado: (2021)

Infusional high-density lipoproteins therapies as a novel strategy for treating atherosclerosis
por: Di Bartolo, Belinda A., et al.
Publicado: (2016)

Therapeutic and Diagnostic Translation of Extracellular Vesicles in Cardiovascular Diseases: Roadmap to the Clinic
por: Sahoo, Susmita, et al.
Publicado: (2021)

Impact of physical activity on inflammation: effects on cardiovascular disease risk and other inflammatory conditions
por: Ertek, Sibel, et al.
Publicado: (2012)

Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmonary Hypertension
por: Calvier, Laurent, et al.
Publicado: (2022)

Targeting hypertriglyceridemia to mitigate cardiovascular risk: A review
por: Toth, Peter P., et al.
Publicado: (2020)

Depression and cardiovascular comorbidity
por: Glassman, Alexander H.
Publicado: (2007)

LDL‐cholesterol and PCSK9 in patients with familial hypercholesterolemia: influence of PCSK9 variants under lipid‐lowering therapy
por: Hamasaki, Masato, et al.
Publicado: (2021)

Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology
por: Ertek, Sibel, et al.
Publicado: (2013)

Aspirin in primary prevention of cardiovascular disease in diabetes
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2021)

Oral health and atherosclerotic cardiovascular disease: A review
por: Gianos, Eugenia, et al.
Publicado: (2021)

Inducing apolipoprotein A-I synthesis to reduce cardiovascular risk: from ASSERT to SUSTAIN and beyond
por: Di Bartolo, Belinda A., et al.
Publicado: (2016)

Can coffee consumption lower the risk of Alzheimer’s disease and Parkinson’s disease? A literature review
por: Wierzejska, Regina
Publicado: (2016)

Modifiable Risk Factors for Cardiovascular Disease in Korea and Japan
por: Arafa, Ahmed, et al.
Publicado: (2021)

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction
por: Nurmohamed, Nick S, et al.
Publicado: (2023)

Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
por: Sao, Rahul, et al.
Publicado: (2017)

Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region
por: Tada, Hayato, et al.
Publicado: (2021)

Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome
por: Hendren, Nicholas S., et al.
Publicado: (2020)

On the present and future role of Lp-PLA(2) in atherosclerosis-related cardiovascular risk prediction and management
por: Fras, Zlatko, et al.
Publicado: (2020)

GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular disease risk in chronic inflammatory diseases()
por: Mehta, Nehal N., et al.
Publicado: (2020)

Ten things to know about ten cardiovascular disease risk factors
por: Bays, Harold E., et al.
Publicado: (2021)

Potential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and galectin-3
por: Hogas, Simona, et al.
Publicado: (2016)

2023: The year in cardiovascular disease – the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?
por: Banach, Maciej, et al.
Publicado: (2023)

Mechanistic Model‐Informed Proarrhythmic Risk Assessment of Drugs: Review of the “CiPA” Initiative and Design of a Prospective Clinical Validation Study
por: Vicente, Jose, et al.
Publicado: (2017)

Ten things to know about ten cardiovascular disease risk factors – 2022
por: Bays, Harold E, et al.
Publicado: (2022)

The cardiovascular burden of light smoking
por: Katsi, Vasiliki, et al.
Publicado: (2021)

There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness
por: Makover, Michael E., et al.
Publicado: (2022)

High-density lipoprotein revisited: biological functions and clinical relevance
por: von Eckardstein, Arnold, et al.
Publicado: (2022)

Kawasaki disease: a comprehensive review
por: Ramphul, Kamleshun, et al.
Publicado: (2018)

Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review
por: Wesley Milks, Michael, et al.
Publicado: (2021)

Placental transfusion: a review
por: Katheria, A C, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lov6g888csu27lklmkfqiq6ggm